Skip to main content
Premium Trial:

Request an Annual Quote

Changing the Way Researchers Are Trained

"The question is, do we need to rethink how academia functions?" asks blogger Michael White at Adaptive Complexity. White draws on a recent article from Louis Menand in Harvard Magazine who writes — though he focuses mostly on the humanities — that graduate education is a "lengthy apprenticeship" that doesn't necessarily prepare those students who will be taking jobs outside of academia. White says the problem isn't as bad in the sciences, but agrees that "there is a huge inefficiency in the training system." White writes:

But do you really need a 7-year PhD in cell biology, followed by a 3-year postdoc to work for Merck doing drug discovery? In many cases, the answer is no, and this is why proposals are floating around for creating professional masters degree programs in the biomedical sciences, much like those that already exist in engineering.
The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.